Skip to main content

研究進程

Pipeline
Product
Indication

BHLA-18 LOTION

Atopic Dermatitis
異位性皮膚炎

60%

45%

BHLA-18 LOTION

Psoriasis
乾癬

40%

40%

BHLA-18 LOTION

Acne vulgaris
痤瘡

40%

40%

BHLA-18 LOTION

Malignant neoplasm. Xerosis cutis.
化療引起的皮膚乾燥

20%

20%

BHLA-18 LOTION

Atopic Dermatitis
異位性皮膚炎

Phase I

45%

BHLA-18 LOTION

Psoriasis
乾癬

Preclinical

40%

BHLA-18 LOTION

Acne vulgaris
痤瘡

Preclinical

40%

BHLA-18 LOTION

Malignant neoplasm. Xerosis cutis.
化療引起的皮膚問題

Discovery

20%